AU2003249121A1 - Use of neomycin in the preparation of medicaments that are used in the treatment of diseases caused by hyperactivation of kinase proteins activated by mitogens (mapk) or by transcription factors - Google Patents

Use of neomycin in the preparation of medicaments that are used in the treatment of diseases caused by hyperactivation of kinase proteins activated by mitogens (mapk) or by transcription factors

Info

Publication number
AU2003249121A1
AU2003249121A1 AU2003249121A AU2003249121A AU2003249121A1 AU 2003249121 A1 AU2003249121 A1 AU 2003249121A1 AU 2003249121 A AU2003249121 A AU 2003249121A AU 2003249121 A AU2003249121 A AU 2003249121A AU 2003249121 A1 AU2003249121 A1 AU 2003249121A1
Authority
AU
Australia
Prior art keywords
hyperactivation
mitogens
mapk
neomycin
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003249121A
Inventor
Pedro Cuevas Sanchez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES200201688A external-priority patent/ES2214105B1/en
Application filed by Individual filed Critical Individual
Publication of AU2003249121A1 publication Critical patent/AU2003249121A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003249121A 2002-07-18 2003-07-18 Use of neomycin in the preparation of medicaments that are used in the treatment of diseases caused by hyperactivation of kinase proteins activated by mitogens (mapk) or by transcription factors Abandoned AU2003249121A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ESP200201688 2002-07-18
ES200201688A ES2214105B1 (en) 2002-07-18 2002-07-18 POMADA FOR THE TREATMENT OF PSORIASIS AND OTHER CUTANEOUS ANGIODEPENDENT DISEASES.
ES200201894 2002-08-09
ESP200201894 2002-08-09
PCT/ES2003/000374 WO2004009081A1 (en) 2002-07-18 2003-07-18 Use of neomycin in the preparation of medicaments that are used in the treatment of diseases caused by hyperactivation of kinase proteins activated by mitogens (mapk) or by transcription factors

Publications (1)

Publication Number Publication Date
AU2003249121A1 true AU2003249121A1 (en) 2004-02-09

Family

ID=30771995

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003249121A Abandoned AU2003249121A1 (en) 2002-07-18 2003-07-18 Use of neomycin in the preparation of medicaments that are used in the treatment of diseases caused by hyperactivation of kinase proteins activated by mitogens (mapk) or by transcription factors

Country Status (2)

Country Link
AU (1) AU2003249121A1 (en)
WO (1) WO2004009081A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060099235A1 (en) * 2004-11-11 2006-05-11 Medtronic Vascular, Inc. Medical devices and compositions useful for treating or inhibiting restenosis
WO2008106248A1 (en) * 2007-03-01 2008-09-04 Board Of Regents, The University Of Texas System Method of cancer treatment with naphthol analogs
CN105169462B (en) * 2015-10-22 2017-10-17 江苏科技大学 Improve the mixed method of neomycinsulphate dispersing uniformity in vaseline

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740372A (en) * 1986-09-17 1988-04-26 Ljubomir Boncic Composition for treating psoriasis vulgaris and a method for its preparation
WO1999058126A1 (en) * 1998-05-11 1999-11-18 The Endowment For Research In Human Biology, Inc. Use of neomycin for treating angiogenesis-related diseases

Also Published As

Publication number Publication date
WO2004009081A1 (en) 2004-01-29

Similar Documents

Publication Publication Date Title
AU2003220317A1 (en) Methods and drug delivery systems for the treatment of orofacial diseases
AU2003206311A1 (en) Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
AU2003206310A1 (en) Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
AU2003264282A1 (en) Phenethanolamine derivatives and their use in the treatment of respiratory diseases
HK1164133A1 (en) Nasal pharmaceutical formulations and methods of using the same
IL163691A (en) 5-phenylthiazole derivatives, process for their preparation, compositions comprising them and use thereof in the preparation of medicaments for the treatment of diseases mediated by pi3 kinase
IL175568A (en) Tyrosine kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating diseases
EP1578421A4 (en) Pharmaceutical preparations for treatments of diseases and disorders of the breast
GB0404693D0 (en) Pharmaceutical preparations for the treatment of ocular surface and other disorders
WO2004006858A3 (en) Compounds, compositions, and methods employing same
WO2003072035A8 (en) Compositions and methods for the treatment of immune related diseases
IL174154A (en) Glp-1 derivatives, pharmaceutical compositions comprising them and their use in manufacturing medicaments
AU2003279338A1 (en) Phenethanolamine derivatives for the treatment of respiratory diseases
IL171683A (en) Immunosuppressant compounds, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for therapy
WO2004024097A9 (en) Compositions and methods for the treatment of immune related diseases
HK1091727A1 (en) Nasal pharmaceutical formulations and methods of using the same
AU2003285091A1 (en) Interferon antagonists useful for the treatment of interferon related diseases
IL162765A (en) Diazabicycle derivatives, processes for their preparation, pharmaceutical compositions comprising them and their medical use
WO2005018605A3 (en) Novel formulation of ropinirole
AU2003297199A1 (en) Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
AU2003255645A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
AU2002368245A1 (en) Matrix type patch for transdermal administration of vitamin d analog and the use thereof
AU2003267532A1 (en) PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES
AU2003236156A1 (en) Pharmaceutical compositions used for immune disease treatment and improvement
TWI347845B (en) Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase